Functional networks underlying cognitive decline in aging and Alzheimer's disease
Functional networks underlying cognitive decline in aging and Alzheimer's disease
批准号:
10758193
负责人:
Jacob Ziontz
金额:
$4.45万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2025-08-31
关键词:
AffectAgeAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAmyloidAmyloid beta-ProteinAreaBehaviorBehavioralBiological MarkersBiometryBrainBrain regionCharacteristicsCognitionCognitiveCognitive agingCommunicationDataData AnalysesDiseaseEducational process of instructingElderlyEnsureEnvironmentEpisodic memoryFellowshipFunctional ImagingFunctional Magnetic Resonance ImagingFutureHippocampusImaging TechniquesImpaired cognitionIndividualLeadMeasuresMediatingMemoryMentorshipNeocortexNerve DegenerationNetwork-basedNeuropsychologyNeurosciencesPathologicPathologyPerformancePositron-Emission TomographyPostdoctoral FellowResearchResearch PersonnelResolutionRestRoleSynapsesTask PerformancesTechniquesTestingTracerTrainingWorkage effectage relatedamyloid pathologybehavioral outcomecareercognitive abilitycognitive changecognitive functioncognitive neurosciencecognitive performanceexecutive functionexperimental studymemory encodingmultimodal neuroimagingneocorticalnetwork dysfunctionneuralneuroimagingneuromechanismnormal agingnovelprospectiveprotein aggregationtau Proteinstau aggregationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Aging and Alzheimer’s disease (AD) are characterized by progressive cognitive decline, ranging from mild to
severe deficits in episodic memory and executive function. In addition, recent work has begun to identify
networks of functional connections across the brain whose activity subserve specific cognitive functions.
Network dysfunction is a feature of AD, but alterations in cognition-related networks may also be detectable in
normal aging. Positron emission tomography (PET) imaging of pathological amyloid-β (Aβ) and tau proteins
has revealed that their accumulation is related to cognitive decline in older adults. The mechanisms by which
these protein aggregates lead to impaired cognitive function are still not well understood, but recent work
suggests that Aβ and tau accumulation may alter the integrity of functional brain networks. This project will
investigate the impact of AD pathology on these networks and their role in age-related cognitive decline. Using
a novel network definition approach, behaviorally-specific functional networks will be defined in older adults
using both resting state and task fMRI data. Neuropsychological episodic memory and executive function
measures as well as memory performance in an fMRI task will be used as behavioral outcomes to define these
networks. In addition, AD pathology will be measured using the 11C-PiB (Aβ) and 18F-Flortaucipir (tau) PET
tracers. In Aim 1, whole-brain resting state functional connectivity will be used to define networks based on
episodic memory and executive function performance, and the overall strength of these networks will be
related to pathology and cognitive performance. In Aim 2, functional connectivity and behavioral data from a
memory encoding fMRI experiment will be used to define a task-based network, which will again be related to
pathology and cognition. Finally, in Aim 3, we will compare these networks in terms of their topography,
relationship with AD pathology, and ability to predict longitudinal cognitive decline. Overall, this study will
investigate changes in functional brain networks as a mechanism by which cognition declines, offering a
compelling new tool for researchers to predict cognitive change in aging and disease. Completion of this
project will provide training in (1) multimodal neuroimaging and processing, (2) novel biostatistical techniques
for neuroimaging data analysis, (3) the cognitive neuroscience of aging and AD, (4) scientific communication,
and (5) teaching and mentorship. The Helen Wills Neuroscience Institute at UC Berkeley provides an ideal
environment for this research, bringing together world-class experts in neuroimaging, biostatistics, and
cognitive neuroscience who will aid in the completion of this project. The sponsor Dr. William Jagust is uniquely
suited for overseeing this work, having built a career on applying multimodal neuroimaging techniques to better
understand the underlying mechanisms of aging and AD. The proposed research and training plans will ensure
the applicant successfully completes the project and is prepared for a competitive post-doctoral fellowship and
research career understanding the neural mechanisms of age- and disease-related cognitive decline.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional networks underlying cognitive decline in aging and Alzheimer's disease
-
批准号:10537411
-
项目类别:
-
资助金额:$4.29万
-
财政年份:2022
-
负责人:Jacob Ziontz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: